Hao Dai, Xianfu Sun, Ya Wei, Xuhui Guo, Chengzheng Wang, Haiquan Jia, Junzhao Wu, Xiuchun Chen, Jianghua Qiao, Chongjian Zhang, Lianfang Li, Jifeng Yu, Ping Li, Peng Yuan, Yadong Sun, Ping Lu, Xin Wang, Qingxin Xia, Zhenduo Lu, Zhenzhen Liu. "Delayed serplulimab combined with nab-paclitaxel and epirubicin in high-risk, early HR+/HER2− breast cancer (HELEN-B 018): A multicenter, single-arm, phase 2 trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.609